BCL2 and neoplasm: The effect of the four tested treatment groups was evaluated on the key apoptotic protein markers (BAX, BCL-2, and caspase 3,7, 8, and) 9 which are vital for stopping tumor progression and the activation of the intrinsic and/or extrinsic apoptotic pathways [30].